Clinical chemistry

This is kind of high, I think, you know, and not in the yellow, but inflammation.

Do we see signs of inflammation on their blood chemistry panel? We see this immune system maybe could be stronger.

We say...

These GI markers are good, but this steatocrit bile flow.

So really big markers to me is making sure H. pylori, we bring that down.

So I did a protocol for that and then working on what autoimmune issues I might have going on.

So then I like to look at blood chemistry panel.

Let's look at this client's blood chemistry panel.

If you look at the the back end of any major hospital laboratory today, you are basically looking at a marvel of modern manufacturing.

I mean, you have these massive multimillion dollar tracks using A.I. and precise robotics to analyze clinical chemistry.

Oh, yeah.

The analytical phases, it's completely industrialized at this point.

So how did this technology actually perform under clinical scrutiny?

Well, the foundational data comes from the landmark ADOPT clinical trial, which stands for Autonomous Blood Drawing Optimization and Performance Testing.

It was recently published in the peer-reviewed journal Clinical Chemistry.

And this was a pretty huge deal, right?